These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1266 related articles for article (PubMed ID: 33776018)

  • 1. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR.
    Olearo F; Nörz D; Heinrich F; Sutter JP; Roedl K; Schultze A; Wiesch JSZ; Braun P; Oestereich L; Kreuels B; Wichmann D; Aepfelbacher M; Pfefferle S; Lütgehetmann M
    J Clin Virol; 2021 Apr; 137():104782. PubMed ID: 33711691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.
    Li L; Tan C; Zeng J; Luo C; Hu S; Peng Y; Li W; Xie Z; Ling Y; Zhang X; Deng E; Xu H; Wang J; Xie Y; Zhou Y; Zhang W; Guo Y; Liu Z
    J Transl Med; 2021 Jan; 19(1):30. PubMed ID: 33413461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the lateral flow immunoassay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
    Somborac Bačura A; Dorotić M; Grošić L; Džimbeg M; Dodig S
    Biochem Med (Zagreb); 2021 Jun; 31(2):020601. PubMed ID: 34140830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
    J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.
    Jakobsen KK; Jensen JS; Todsen T; Tolsgaard MG; Kirkby N; Lippert F; Vangsted AM; Martel CJ; Klokker M; von Buchwald C
    Dan Med J; 2021 Jun; 68(7):. PubMed ID: 34169830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?
    Cento V; Renica S; Matarazzo E; Antonello M; Colagrossi L; Di Ruscio F; Pani A; Fanti D; Vismara C; Puoti M; Scaglione F; Perno CF; Alteri C; On Behalf Of The S Co Va Study Group
    Viruses; 2021 May; 13(5):. PubMed ID: 34062916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.